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Abstract
Background: Translocation of nanoparticles (NP) from the pulmonary airways into other
pulmonary compartments or the systemic circulation is controversially discussed in the literature.
In a previous study it was shown that titanium dioxide (TiO2) NP were "distributed in four lung
compartments (air-filled spaces, epithelium/endothelium, connective tissue, capillary lumen) in
correlation with compartment size". It was concluded that particles can move freely between these
tissue compartments. To analyze whether the distribution of TiO2 NP in the lungs is really random
or shows a preferential targeting we applied a newly developed method for comparing NP
distributions.
Methods: Rat lungs exposed to an aerosol containing TiO2 NP were prepared for light and
electron microscopy at 1 h and at 24 h after exposure. Numbers of TiO2 NP associated with each
compartment were counted using energy filtering transmission electron microscopy.
Compartment size was estimated by unbiased stereology from systematically sampled light
micrographs. Numbers of particles were related to compartment size using a relative deposition
index and chi-squared analysis.
Results: Nanoparticle distribution within the four compartments was not random at 1 h or at 24
h after exposure. At 1 h the connective tissue was the preferential target of the particles. At 24 h
the NP were preferentially located in the capillary lumen.
Conclusion: We conclude that TiO2 NP do not move freely between pulmonary tissue
compartments, although they can pass from one compartment to another with relative ease. The
residence time of NP in each tissue compartment of the respiratory system depends on the
compartment and the time after exposure. It is suggested that a small fraction of TiO2 NP are
rapidly transported from the airway lumen to the connective tissue and subsequently released into
the systemic circulation.
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A growing number of epidemiological studies suggests
that airborne particles convey adverse health effects in
humans causing increased morbidity and mortality [1-3].
Experimental work has provided evidence for the genera-
tion of reactive oxygen species as well as inflammatory
and genotoxic responses upon exposure to particulate
matter both in animal models and in vitro studies [4-8].
In recent years special emphasis has been placed on parti-
cles smaller than 100 nm at least in one dimension [9].
These are usually referred to as ultrafine particles if they
have their origin in gas-to-particle conversion or incom-
plete combustion processes or as nanoparticles (NP) if
they are manufactured synthetically. In the following, we
use the term NP independent of particle origin or shape.
The growing interest of toxicologists in NP is mainly due
to the following reasons: First, the obvious advances made
in nanotechnology are accompanied by a lack of knowl-
edge about the potential health risks of NP [9]. Second,
while nanotechnology exploits the fact that NP may
exhibit different biophysicochemical characteristics than
particles of the same material at a larger scale [10], these
differences may also hold true for the interaction of NP
with biological systems [11]. In consequence, the produc-
tion of NP, even if composed of materials formerly not
known to be toxic, and the subsequent occurrence of NP
in water, soil or air will sooner or later bring about an
exposition of humans to NP. Due to the large size of the
alveolar surface (approximately 140 m2 in the human)
and the minimal distance between air and blood (approx-
imately 0.2 – 0.4 µm in the thin regions), the lungs are an
ideal portal of entry for airborne NP [12].
One intriguing question relates to the translocation char-
acteristics of NP. Despite a growing body of literature,
there is still a controversial debate whether NP are able to
cross the pulmonary blood-air barrier and, hence, are
translocated to the blood circulation in a significant
amount [13,14]. Interestingly, animal and in vitro studies
provide evidence for such translocation properties of NP
[15,16] whereas most investigations in the human show a
very limited translocation to the circulation if any [14,17].
In fact, in a recent study we were able to show that tita-
nium dioxide (TiO2) NP are able to cross cellular mem-
branes in a rat lung exposure model that did not involve
commonly known phagocytotic mechanisms [18]. This
study raised the possibility of TiO2 NP being able to enter
cells and tissues in a rather unrestricted fashion. A corol-
lary of such particle characteristics would be a random
particle distribution, i.e. the number of particles observed
within a certain compartment should be correlated to the
size of the compartment. Indeed, Geiser et al. [18] pro-
vided a Figure (Figure 1) that related the volume fractions
of pulmonary compartments to the number of counted
particles. At that time, it was concluded from the correla-
tion between volume fractions and particle numbers that
"particles can move between tissue compartments with-
out restraint" [18].
Very recently, however, a new method was developed to
analyse the distributions of NP within tissues, cells or cell
organelles in more detail [19]. The new method basically
relates the size of a tissue (or intracellular) compartment
to the number of particles located within a particular com-
partment. From these data, a relative deposition index
(RDI) can be calculated which indicates whether a com-
partment contains more (RDI > 1), the same (RDI = 1) or
less (RDI < 1) particles than would be expected from its
size. Using the chi-squared test, we can further test the
null hypothesis that the distribution of NP among the tis-
sue compartments is random and if not, identify those
compartments which contribute substantially to this dif-
ference. Those compartments with an RDI > 1 and a sub-
stantial contribution to the non-randomness of particle
localization are identified as preferential targets of the par-
ticles.
As this method is very sensitive and reliable for analysing
the distribution of particles in relation to compartment
size the present study investigates whether the particle dis-
tribution reported by Geiser et al. [18] is really random or
shows a preferential localization of the particles. The con-
clusions that can be drawn from this re-evaluation are
important for understanding particle translocation char-
acteristics because we show that particle distributions are
neither random at 1 h or at 24 h after exposure. This result
contradicts the former concept of an unrestricted NP
movement [18] and rather points to controlled transloca-
tion processes.
Results and Discussion
In the present study we re-evaluated the distribution of
titanium dioxide NP in lung tissue of rats exposed to an
aerosol containing NP for 1 h. The tissue distribution of
NP was analyzed at 1 h and at 24 h after exposure. The
rationale for the re-evaluation was that the original report
[18] had already related the number of NP associated with
each compartment to the compartment size (Fig. 1) but a
sound tool to compare these data statistically was lacking.
Very recently, some of the authors have adopted a quanti-
tative method for analyzing the intracellular distribution
of immunogold particles [20,21] to NP research. This
method was originally introduced using hypothetical sets
of data [19] and allows the analysis of NP distributions in
tissue and cellular compartments in a very sensitive and
statistically valid way. The results of this analysis are
reported in Tables 1 and 2 and in Figures 2 and 3.Page 2 of 8
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report, the present study shows that the distribution of NP
within the four defined pulmonary tissue compartments
is neither random after 1 h nor after 24 h after exposure.
The null hypotheses tested in the analyses were: "The
observed and expected NP distributions are equal." With
three degrees of freedom (4-1 compartments × 2-1
groups) the null hypothesis of random distribution had to
be rejected with p < 0.01 in both cases. This result indi-
cates that despite the seeming correlation seen in Fig. 1,
there is a statistically significant difference between the
observed NP distribution and that expected from com-
partment size. With the definition that a preferential com-
partment localization of the particles has to meet two
criteria, namely RDI > 1 and partial chi-squared/total chi-
squared > 10%, we can identify the connective tissue as
the preferential target of NP at 1 h after exposure and the
capillary lumen as the preferential target at 24 h after
exposure. Therefore, NP distribution within the four com-
partments is not only non-random but there is also a
change in the preferential localization due to time after
exposure. We found a preferential localization in the con-
nective tissue at 1 h and in the capillary lumen at 24 h
after exposure.
Although it is not possible to provide a clear mechanistic
image of the translocation characteristics of TiO2 NP from
these data alone there are several conclusions that can be
drawn from the results. First of all, the data do not support
the hypothesis that NP can travel between different pul-
monary compartments without restraint. In such case, all
compartments should have had an RDI of approximately
1 and the total chi-squared would not have reached the
significance level [19]. Second, NP seem to be transported
from the airspaces to the connective tissue rapidly after
exposure which includes that the epithelium is rather a
transit passage for NP than a preferential target. However,
a third conclusion is that NP are not transported to the
connective tissue for being deposited for long time storage
since they do not contribute substantially to the non-ran-
domness of the distribution at 24 h after exposure. In fact,
after 24 h the preferential target of the NP is the capillary
lumen which indicates that NP are shifted from the con-
nective tissue into the circulation where they are retained.
It needs to be mentioned at this point that the counting of
the particles inside the capillary lumen raises several
issues. The capillary lumen and, hence, the blood is a non-
Table 1: Analysis of TiO2-nanoparticle distribution 1 h after exposure.
Compartment NO P NE RDI Χ2 Fraction of total Χ2
Air 348 2251 378 0.920 2.42 0.071
Epi/Endo 29 151 25 1.143 0.52 0.015
CT 28 63 11 2.645 28.64 0.842
Caplum 44 207 35 1.265 2.44 0.072
Total 449 2672 449 34.02
Note. From the observed number of particles (NO) and the number of points (P) on each compartment the expected number of particles (NE) was 
calculated (e.g. NE (air) = 449 × (2251/2672) = 378). The RDI is calculated from NO/NE (e.g. RDI (air) = 348/378 = 0.92). The chi-squared (Χ2) 
values are calculated from (NO - NE)2/NE (e.g. Χ2 (air) = (348–378)2/378 = 2.42). With three degrees of freedom (2-1 groups × 4-1 compartments) 
and a total chi-squared value of 34.02, the null-hypothesis of random distribution has to be rejected (p < 0.01). The connective tissue has an RDI of 
2.645 and a partial chi-squared value that contributes about 84% of the total chi-squared. It is the only compartment that meets both criteria for a 
preferential deposition. Abbreviations: Air: Air space; Epi/Endo: Epithelial/endothelial cells; CT: Connective tissue; Caplum: Capillary lumen. Χ2: 
Chi-squared test values. NO: Observed number of particles. NE: Expected number of particles. RDI: Relative deposition index.
Original data from Geiser et al. [18] showing the mean number of TiO2 NP in the four defined tissue compartments at 1 h n  at 24 h aft r xp sureFigur  1
Original data from Geiser et al. [18] showing the mean 
number of TiO2 NP in the four defined tissue compartments 
at 1 h and at 24 h after exposure. Volume fractions of the 
compartments are also shown. Reproduced from Geiser et 
al. [18]. With permission.Page 3 of 8
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inside the circulation may be expected to be higher than
the number counted. However, NP were observed in the
free lumen, mostly near but not in direct contact to the
capillary endothelium. Upon additional screening, very
few particles were also observed inside erythrocytes left in
the capillaries. Therefore, due to the non-static nature of
the circulation and the mode of fixation (perfusion fixa-
tion) the number of NP inside the capillaries was possibly
underestimated in the present study.
How do these results and conclusions fit into the current
knowledge about NP translocation from the airspaces to
the blood circulation? It is well known that NP, in contrast
to larger sized particles, reach the alveolar region of the
lung and remain there for a much longer period of time
after exposure [22]. Furthermore, Oberdörster et al. [22]
showed that a large fraction of the retained NP was
present in the interstitial space but decreased after a cer-
tain period of time after exposure. In a more recent study,
Takenaka et al. [23] studied the translocation of ultrafine
gold particles in rat lungs during several days after a 6 h
inhalation exposure. They found that the gold particles
were taken up by alveolar macrophages and epithelial
cells and were also present in the blood circulation. Krey-
ling et al. [24] showed a translocation of iridium NP from
the lungs to extrapulmonary organs and the circulation
which was very low. Nemmar et al. [13] provided evi-
dence for a significant translocation of inhaled carbon NP
to the blood circulation, however, when they used poly-
styrene particles in an isolated rabbit lung model they did
not observe such translocation [25]. The concept of a sig-
nificant clearance of NP by translocation to the circulation
has been challenged by two recent studies (similarly
designed as [13]) on inhaled carbonaceous particles
[14,17]. These authors did not find evidence for a signifi-
cant clearance of NP retained in the human lung, espe-
cially not by the blood circulation.
In light of these studies, our analysis supports the concept
of pulmonary clearance of TiO2 NP through the microvas-
culature, however, the RDI must not be misunderstood
with respect to the total number of NP. In relation to the
total number of NP within the lung the number of TiO2
NP observed within the capillaries is still very low (Tables
1 and 2). Other routes of clearance (exhalation, mucocili-
ary escalator) which may decrease the number of NP
would certainly decrease the total number of observed NP
and therefore increase the RDI for the other compart-
ments. Nonetheless, clearance from the airspaces via the
bronchial tree seems to be very low and NP are retained in
the lungs for a long period of time [22,23] and particles
were still present in the airspaces to a similar extent in the
rat lungs at 24 h after exposure compared with those at 1
Table 2: Analysis of TiO2-nanoparticle distribution 24 h after exposure.
Compartment NO P NE RDI Χ2 Fraction of total Χ2
Air 348 2052 363 0.96 0.59 0.039
Epi/Endo 17 131 23 0.73 1.63 0.109
CT 11 54 10 1.15 0.22 0.015
Caplum 49 168 30 1.65 12.56 0.837
Total 425 2405 425 15.01
Note. The calculation of the data is described in the Methods section and an illustrating example is provided in the note to table 1. With three 
degrees of freedom (2-1 groups × 4-1 compartments) and a total chi-squared value of 15.01, the null-hypothesis of random distribution has to be 
rejected (p < 0.01). The capillary lumen has an RDI of 1.65 and a partial chi-squared value that contributes about 84% of the total chi-squared. It is 
the only compartment that meets both criteria for a preferential deposition. Abbreviations: Air: Air space; Epi/Endo: Epithelial/endothelial cells; CT: 
Connective tissue; Caplum: Capillary lumen. Χ2: Chi-squared test values. NO: Observed number of particles. NE: Expected number of particles. RDI: 
Relative deposition index.
Illustration of the observed (white columns) and the expected (black columns) NP w hin the four tissue compart-ments at 1 h after expo ureFigu e 2
Illustration of the observed (white columns) and the 
expected (black columns) NP within the four tissue compart-
ments at 1 h after exposure. The total chi-squared showed 
that the distributions of observed and expected particles dif-
fered significantly. There is only one compartment with an 
RDI > 1 and a substantial contribution to the total chi-
squared: the connective tissue is the only compartment that 
is preferentially targeted by the NP at 1 h after exposure.Page 4 of 8
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evaluate whether this translocation to the circulation has
functional significance and may cause adverse health
effects. However, the data do support that the circulation
is a preferential target of retained NP. Obviously, the com-
parison between the many different studies on particle
translocation is hampered by the application of different
types of species and NP, exposure models and durations,
the duration between exposure and analysis and other fac-
tors. The different physicochemical properties of the NP
applied in the studies may be the most influential factor
and may seriously influence the translocation characteris-
tics. In this regard, it has been recognized that there is a
need to standardize several experimental procedures in
order to make studies comparable [9]. However, the
present study also underlines the necessity of expressing
NP distributions in quantitative terms and in relation to
compartment size. We believe that this new quantitative
microscopic method – if regularly applied – will help to
enhance the comparability between studies where NP dis-
tribution is relevant because it combines the high resolu-
tion of transmission electron microscopy with a reliable
statistical tool. It will also enhance the correlation
between morphological observation and functional
results.
Conclusion
The present study contributes to the understanding of
nanoparticle translocation characteristics in the lung. It
showed that the distribution of inhaled titanium dioxide
particles in the rat lung was not random, thus pointing at
a regulated translocation process rather than a diffusive
particle movement. The connective tissue was the prefer-
ential target of the studied particles at 1 h after exposure.
A significant translocation and retention of the particles
took place during the subsequent period, making the cap-
illary lumen the preferential target at 24 h after exposure.
The present study also stresses the need and usefulness of




The experiments investigated in the present study were
described in detail previously [18]. Important methodo-
logical features of the experiments are given in Table 3.
Table 3: Important methodological issues of the experiments. For details see Geiser et al. [18].
Animals
Species Adult male WKY/NCrl BR rats
Number n = 5 for each group
Particles
Material Titanium dioxide
Aerosol generation Spark generator (Palas) in a pure argon plus 0.1% oxygen stream
Count median diameter (nm) 22 (SD 1.7)
Exposure Inhalation of aerosol for 1 h
Fixation and tissue processing
Time point of fixation 1 h or 24 h after particle exposure
Fixation mode Subsequent perfusion fixation with 2.5% buffered glutaraldehyde, 1% 
osmium tetroxide, 0.5% uranyl acetate
Tissue sampling Systematic uniform random sampling
Material for light and electron microscopy Semithin (toluidine staining) and ultrathin (uranyl acetate and lead citrate 
staining) sections
Illustration of the observed (white columns) and the expected (black columns) NP w hin the four tissue compart-ments at 24 h after exposureFigu e 3
Illustration of the observed (white columns) and the 
expected (black columns) NP within the four tissue compart-
ments at 24 h after exposure. The total chi-squared showed 
that the distributions of observed and expected particles dif-
fered significantly. There is only one compartment with an 
RDI > 1 and a substantial contribution to the total chi-
squared: the capillary lumen is the only compartment that is 
preferentially targeted at 24 h after exposure.Page 5 of 8
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From the qualitative investigation, four major compart-
ments had been defined in which the TiO2 particles were
found: air-filled spaces, connective tissue, epithelium/
endothelium, capillary lumen. Titanium dioxide NP
numbers associated with each compartment were taken
from the original data published by Geiser et al. [18].
Briefly, the original data were gathered by counting parti-
cle profiles in systematic uniform random test fields of
ultrathin tissue sections using a LEO 912 transmission
electron microscope (Zeiss, Oberkochen, Germany). Par-
ticle identity was verified by element analysis (energy fil-
tering transmission electron microscopy) as described in
detail previously [26,27].
In the original report, information about compartment
size was taken from older studies on rat myocardium [18].
For this study, compartment size was estimated from the
same lungs that were used for counting NP numbers. In
short, semithin sections of pulmonary tissue were sam-
pled in a systematic uniform random fashion [28,29]
using an Axioskope light microscope (Zeiss, Oberkochen,
Germany) equipped with a computer assisted stereology
tool (CAST-Grid 2.0, Olympus, Denmark). On each test
field, a point grid was superimposed and points hitting
the defined compartments were counted. The number of
points hitting each compartment is an unbiased measure
for the size (volume) of each of the compartments [30].
Since the total numbers of particles and points counted
for each animal were different and every animal should
make the same contribution to the further analysis, the
raw counts were converted to normalized point and parti-
cle counts by multiplying the total counts with the mean
fraction of each compartment. Data of raw and normal-
ized particle and point counts are given in Table 4.
Relative deposition index and chi-squared analysis
The normalized data entered a statistical analysis based on
the comparison between observed and expected particle
distributions using the chi-squared (Χ2) test [19]. The
observed distribution of particles is given by the number
of particles associated with each compartment. The
expected distribution of particles is based on the hypo-
thetical assumption of random particle distribution. If
particles were expected to be distributed randomly within
the pulmonary compartments then the number of parti-
cles associated with each compartment would correlate
with the compartment size which is given by the observed
number of points.
Therefore, the expected number of particles for each com-
partment (NE (comp)) can be calculated from the total
number of observed particles (NO (total)) and the num-
bers of observed points in total (P (total)) and for each
compartment (P (comp)):
NE (comp) = NO (total) × (P(comp)/P (total))
The relative deposition index (RDI) indicates whether the
number of observed particles is higher (RDI > 1) or lower
(RDI < 1) than the expected number. If RDI = 1, the
observed and expected numbers of particles are equal. The
RDI is given by:
RDI = NO (comp)/NE (comp)
with NO (comp) being the number of particles counted
within one of the compartments.
A convenient way to compare observed and expected dis-
tributions is the chi-squared test [31]. Here, it was used to
compare the observed and expected NP distributions or,
in other words, to test the null hypothesis of random par-
ticle distribution. Partial chi-squared values (partial Χ2)
are calculated as follows:
Table 4: Number of observed points and particles
Air Epi/Endo CT Caplum Total
P (1 h) 2250 ± 396 153 ± 46 63 ± 10 206 ± 51 2672 ± 478
P (24 h) 2058 ± 445 128 ± 12 54 ± 12 165 ± 19 2405 ± 470
Normalized P (1 h) 2251 ± 62 151 ± 30 63 ± 9 207 ± 43 2672
Normalized P (24 
h)
2052 ± 42 131 ± 19 54 ± 4 168 ± 28 2405
NO (1 h) 343 ± 218 35 ± 40 33 ± 38 38 ± 20 449 ± 283
NO (24 h) 354 ± 193 15 ± 9 14 ± 15 44 ± 12 426 ± 218
Normalized NO (1 
h)
348 ± 45 29 ± 27 28 ± 27 44 ± 20 449
Normalized NO (24 
h)
348 ± 25 17 ± 13 11 ± 9 49 ± 20 426
Note. Air: Air space; Epi/Endo: Epithelial/endothelial cells; CT: Connective tissue; Caplum: Capillary lumen; NO: Number of observed particles; P: 
Number of points.Page 6 of 8
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The total chi-squared value is calculated by adding up all
partial chi-squared values. It indicates whether the
observed and expected distributions are equal, i.e.
whether the null hypothesis of random particle localiza-
tion can be accepted. If this is not the case, we can identify
compartments of preferential particle localization if two
criteria are met: the RDI is larger than 1 and the partial chi-
squared value of this compartment contributes substan-
tially (a convenient value is 10% or more) to the total chi-





RDI - Relative deposition index.
NE (comp)- Number of expected particles for a particular
compartment.
NO (comp)- Number of observed particles for a particular
compartment.
NO (total)- Total number of observed particles.
P (comp)- Number of points hitting a particular compart-
ment.
P (total)- Total number of points.
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